SIRIO Pharma Announces Global Collaboration
Proactive innovation specialists located in Asia, Europe and the United States to combine Research and Development efforts Asia, Europe & The United States, 10 April, 2019: Sirio Pharma (SIRIO) – the nutraceutical contract development and manufacturing organization (CDMO) – announces global collaboration to help customers bring innovative, safe and effective products quickly to market. With access to the most recent market data, Sirio’s 100+ scientists and industry experts, based in Asia, Europe and the United States, will combine research and development efforts…